Etofenamate

Etofenamate

SCHEMBL28772901

C=CCc1ccc(O)c(OC)c1.O=C(OCCOCCO)c1ccccc1Nc1cccc(C(F)(F)F)c1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.69
▸ CYP1A2 P05177 1/20 0.69
▸ CYP2C9 P11712 1/20 0.69
▸ CYP2C19 P33261 1/20 0.69
▸ RXFP1 Q9HBX9 8/20 0.44
▸ YAP1 P46937 1/20 0.42
▸ TEAD4 Q15561 1/20 0.42
▸ TEAD2 Q15562 1/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ ALOX5 P09917 1/20 0.42
▸ AR P10275 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ TRPM8 Q7Z2W7 1/20 0.42
▸ SIRT2 Q8IXJ6 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ACHE P22303 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etofenamate SCHEMBL25152 0.83 LMNA (1.00) LMNACYP1A2CYP2C9CYP2C19RXFP1
Etofenamate SCHEMBL6836167 0.80 LMNA (0.92) LMNACYP1A2CYP2C9CYP2C19RXFP1
SCHEMBL12715082 0.79 LMNA (0.91) LMNACYP1A2CYP2C9CYP2C19RXFP1
SCHEMBL11494752 0.74 LMNA (0.67) LMNACYP1A2CYP2C9CYP2C19RXFP1
SCHEMBL10631533 0.73 LMNA (0.78) LMNACYP1A2CYP2C9CYP2C19RXFP1
Etofenamate SCHEMBL13731241 0.71 LMNA (0.71) LMNACYP1A2CYP2C9CYP2C19RXFP1
Etofenamate SCHEMBL28086507 0.71 LMNA (0.71) LMNACYP1A2CYP2C9CYP2C19RXFP1
Ufenamate SCHEMBL29376700 0.71 CYP1A2 (0.72) LMNACYP1A2CYP2C9CYP2C19RXFP1
Ufenamate SCHEMBL36095 0.71 CYP1A2 (0.72) LMNACYP1A2CYP2C9CYP2C19RXFP1
SCHEMBL10597386 0.71 LMNA (0.71) LMNACYP1A2CYP2C9CYP2C19RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101163717-A Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases HALOZYME THERAPEUTICS INC (US) 2008-04-16 — — CN disclosed
Send feedback